Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Power1on Jan 11, 2020 12:25pm
132 Views
Post# 30542244

RE:RE:Analyst Coverage

RE:RE:Analyst CoverageGreat comments.   You forgot to include 360 Networks.......funny how that one went under and then the assets moved to another for pennies on the dollar (what does this look like for the weed sector).  I've seen a lot of road rash over the years.  

It is as you mentioned a great parallel and one of the reasons I have refrained from jumping on the weed wagon.  Now I sit and wait for the carnage as the only longer term savior in my opinion would be significant growth in near term sales and the trends are not looking like that will happen or at least not to a level to ward off 

Is cannibas 2.0 a catalyst?  Likely have to wait 2 qrters to see what the uplift is. My guess is we will see incremental growth overtime and perhaps a one time early surge of consumers that will go and try edibles.

Question for me is what does ACB need to do before that time to ensure they are sufficiently liquid and how will this drive down share value. 

The further the shareprice drops, the higher the dilution will be.   There maybe other options available to the company but I cant see how they can avoid rolling back shares as part of a plan to raise capital.  I'm not familiar with any company where pre-consolidation investors didn't get thumped on a roll back. 

time will tell. 

 
Bullboard Posts